CTLA4 and neoplasm: Recently, we developed CAF-rich murine tumour models to investigate the effect of CAF on the immune microenvironment and immunotherapy response.3 This showed that CD8 T cells fail to infiltrate CAF-rich tumours, instead accumulating at the tumour margin, and upregulating expression of CTLA-4.